Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.

Teva-Ranitidine (2016-06-09)

Starting date:
June 9, 2016
Posting date:
June 17, 2016
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-58946

Affected products

A. Teva-Ranitidine

Reason

Tablets were discoloured.

Depth of distribution

Pharmacies (AB, BC, MB, SK, ON, QC, NB, NS, NL)

Affected products

A. Teva-Ranitidine

DIN, NPN, DIN-HIM
00828556
Dosage form

Tablets

Strength

300mg

Lot or serial number

Lot 35341399A
Lot 35341400A

Companies
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA